Literature DB >> 22173096

Nucleo-cytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling.

Yan Li1, Yangguang Shao, Yuxin Tong, Tao Shen, Jian Zhang, Yanshu Li, Hui Gu, Feng Li.   

Abstract

The canonical Wnt/β-catenin signaling pathway plays a central role in development and cancer. The p21-activated kinase 4 (PAK4) involves in a wide range of cellular processes, including cytoskeletal reorganization, cell proliferation, gene transcription and oncogenic transformation. However, the cross talk between the Wnt and PAK4 signaling pathways is poorly understood. Here, we show that PAK4 is a nucleo-cytoplasmic shuttling protein, containing three nuclear export signals (NESs) and two nuclear localization signals (NLSs). PAK4 is exported by the chromosome region maintenance-1 (CRM-1)-dependent pathway and is imported into the nucleus in an importin α5-dependent manner. PAK4 interacts with and phosphorylates β-catenin on Ser675, which promotes the TCF/LEF transcriptional activity and stabilizes β-catenin through inhibition of its degradation. Moreover, nuclear import of PAK4 accompanies with the nuclear import of β-catenin and increased TCF/LEF transcriptional activity. We further demonstrated that PAK4 associates with the TCF/LEF transcriptional complex by ChIP assays. These findings uncover a novel role for PAK4 in modulating intracellular translocation and signaling of β-catenin.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173096     DOI: 10.1016/j.bbamcr.2011.11.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  54 in total

1.  PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.

Authors:  Elizabeth M Morse; Xiaowen Sun; Jordan R Olberding; Byung Hak Ha; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2015-11-23       Impact factor: 5.285

Review 2.  Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

Authors:  Yang-Guang Shao; Ke Ning; Feng Li
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 3.  Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.

Authors:  Byung Hak Ha; Elizabeth M Morse; Benjamin E Turk; Titus J Boggon
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

4.  Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.

Authors:  Omran Abu Aboud; Ching-Hsien Chen; William Senapedis; Erkan Baloglu; Christian Argueta; Robert H Weiss
Journal:  Mol Cancer Ther       Date:  2016-07-07       Impact factor: 6.261

Review 5.  p21-Activated Kinases in Thyroid Cancer.

Authors:  Luis Bautista; Christina M Knippler; Matthew D Ringel
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

6.  p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.

Authors:  Cheong-Yong Yun; Soon-Tae You; Jin-Hwa Kim; Jin H Chung; Sang-Bae Han; Eun-Young Shin; Eung-Gook Kim
Journal:  J Invest Dermatol       Date:  2015-01-05       Impact factor: 8.551

Review 7.  Rho GTPase effectors and NAD metabolism in cancer immune suppression.

Authors:  Mahmoud Chaker; Audrey Minden; Suzie Chen; Robert H Weiss; Eduardo N Chini; Amit Mahipal; Asfar S Azmi
Journal:  Expert Opin Ther Targets       Date:  2017-12-10       Impact factor: 6.902

8.  Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.

Authors:  Mariateresa Fulciniti; Joaquin Martinez-Lopez; William Senapedis; Stefania Oliva; Rajya Lakshmi Bandi; Nicola Amodio; Yan Xu; Raphael Szalat; Annamaria Gulla; Mehmet K Samur; Aldo Roccaro; Maria Linares; Michele Cea; Erkan Baloglu; Christian Argueta; Yosef Landesman; Sharon Shacham; Siyuan Liu; Monica Schenone; Shiaw-Lin Wu; Barry Karger; Rao Prabhala; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

9.  Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia.

Authors:  S Takao; W Chien; V Madan; D-C Lin; L-W Ding; Q-Y Sun; A Mayakonda; M Sudo; L Xu; Y Chen; Y-Y Jiang; S Gery; M Lill; E Park; W Senapedis; E Baloglu; M Müschen; H P Koeffler
Journal:  Leukemia       Date:  2017-09-14       Impact factor: 11.528

10.  Positive cross talk between protein kinase D and β-catenin in intestinal epithelial cells: impact on β-catenin nuclear localization and phosphorylation at Ser552.

Authors:  Jia Wang; Liang Han; James Sinnett-Smith; Li-Li Han; Jan V Stevens; Nora Rozengurt; Steven H Young; Enrique Rozengurt
Journal:  Am J Physiol Cell Physiol       Date:  2016-01-06       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.